DCMIC

Decheng Capital Management III (Cayman) Portfolio holdings

AUM $300M
1-Year Est. Return 15.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+15.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$300M
AUM Growth
-$19.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
32
New
Increased
Reduced
Closed

Top Buys

1
+$82.6M
2
+$16.5M
3
+$10.4M
4
AURA icon
Aura Biosciences
AURA
+$9.36M
5
IMGN
Immunogen Inc
IMGN
+$6.92M

Top Sells

1
+$69M
2
+$814K
3
+$674K
4
SLRN
ACELYRIN
SLRN
+$130K
5
NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
+$92.5K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACET icon
26
Adicet Bio
ACET
$62.9M
$274K 0.09%
12,513
-19,091
NBSE
27
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
– –
-50,000
APGN
28
DELISTED
Apexigen, Inc. Common Stock
APGN
– –
-1,894,551
ALP.PRN
29
DELISTED
Alabama Power Co 5.20% CL-A PRF
ALP.PRN
– –
-6,708,288
1
2